Oxford/AstraZeneca vaccine to be tested on children aged 6yrs to 17yrs
Trial will use 300 volunteers to assess whether jab produces strong immune response in children aged six to 17
Researchers will use 300 volunteers to assess whether the jab – known as the the ChAdOx1 nCoV-19 vaccine – produces a strong immune response in children aged between six and 17.
Image by press 👍 and ⭐ from Pixabay
** This post was originally published on February 13, 2021 **